search
Back to results

Noninferiority Clinical Trial With Laryngeal Mask and Endotracheal Tube

Primary Purpose

Laryngospasm, Bradycardia

Status
Unknown status
Phase
Phase 3
Locations
Colombia
Study Type
Interventional
Intervention
Airway laryngeal mask classic
endotracheal tube
Sponsored by
Universidad de Antioquia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Laryngospasm focused on measuring Airway, Airway laryngeal mask, Endotracheal tube, Respiration artificial, Laryngospasm, Safety of airway laryngeal mask

Eligibility Criteria

2 Years - 14 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • ASA I and III children, 1-14 years of age
  • Children scheduled for surgery or therapeutic procedures under general anesthesia and fasting as defined in the fasting guidelines
  • Responsible adult patients whose accept and sign the informed consent of study

Exclusion Criteria:

  • Surgery of the head, neck, chest and/or abdomen (except the abdominal wall)
  • Position different than the supine in surgery
  • Malformations or anatomic abnormalities of the face and airway
  • Procedures over 3 hours
  • Patients with pulmonary aspiration risk: morbid obesity, intestinal obstruction, gastrointestinal bleeding, gastroparesis, gastroesophageal reflux
  • Patients with limited mouth opening or cervical spine extension and classified as difficult airway

Sites / Locations

  • Hospital Foundation St. Vincent de Paul

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Airway laryngeal mask classic

endotracheal tube

Arm Description

Ventilation with Airway laryngeal mask classic during surgery

Ventilation with endotracheal tube during surgery

Outcomes

Primary Outcome Measures

Laryngospasm clinically manifested as inspiratory stridor and/or expiratory, no breath sounds, paradoxical movement of the thorax and abdomen and desaturation, bradycardia, central cyanosis.
It should be noted that once the subject of study presents the primary outcome may end up changing the device to improve ventilation.

Secondary Outcome Measures

Desaturation defined as SaO2 < 90% in pulse oximetry associated with laryngospasm
Presence of bradycardia in the cardioscope as reported for the age.

Full Information

First Posted
January 31, 2011
Last Updated
July 25, 2012
Sponsor
Universidad de Antioquia
search

1. Study Identification

Unique Protocol Identification Number
NCT01288248
Brief Title
Noninferiority Clinical Trial With Laryngeal Mask and Endotracheal Tube
Official Title
The Risk of Laryngospasm in Children is Similar to the Use of the Laryngeal Mask and the Endotracheal Tube in Children 2 Years to 14 Years: Clinical Trial Randomized Noninferiority
Study Type
Interventional

2. Study Status

Record Verification Date
July 2012
Overall Recruitment Status
Unknown status
Study Start Date
January 2012 (undefined)
Primary Completion Date
October 2013 (Anticipated)
Study Completion Date
December 2013 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad de Antioquia

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether the use of laryngeal mask classic as method for securing the airway in the population of 2 years to 14 years is associated with risk of laryngospasm as compared with the use of endotracheal tube.
Detailed Description
Laryngospasm, defined as closure of the glottis as a protective reflex secondary to abnormal stimulation (7), with a reported incidence in the general population of 8.7 per 1000 patients undergoing surgical procedures (8), is considered the most common event among the complications in the management of pediatric airway, causing 40% of obstructive events after extubation (7-8), with incidents reported in the American pediatric population from 0.4% to 14% (8-9) for population under 6 years and 3.6% in > 6 years. Among the risk factors associated with the development of laryngospasm and anesthesia in children are: age, ASA (4), upper respiratory infection (10), among others, however in recent years has gained interest and generated dispute the association between this outcome and the type of device used to secure the airway during anesthesia. Although the endotracheal tube device is considered the "gold standard" for airway management, this has been associated with an increased incidence of laryngospasm (8), explained this phenomenon, apparently by direct stimulation because the tube into the larynx and trachea, which triggers, in theory, a posterior laryngeal reflex intense (11). In recent years, with the advent of new devices for securing the airway, especially supraglottic use type Classic Laryngeal Mask (LM), it was thought that the main trigger of laryngospasm, laryngeal and tracheal stimulation caused by the endotracheal tube (ETT), would be resolved and will decrease the incidence of complications in the pediatric population; however, three recent prospective studies (10-11-12) is no statistically significant difference in incidence of laryngospasm among laryngeal mask and endotracheal tube. By contrast, two retrospective studies (6.4) have shown increased incidence of laryngospasm compared to ETT in children. In 2002, one of the aforementioned prospective studies (11), found an incidence of laryngospasm 11.2% versus 16.9% for ETT versus ML, respectively, but without an increase in relative risk statistically significant when comparing the ML to ETT. In view of these findings and considering that most studies in this respect seem to have technical and methodological limitations, our objective is to determine by controlled clinical trial non inferiority the risk of laryngospasm with the endotracheal tube vs a device supraglottic, Classic Laryngeal Mask type as a method of airway patency in the pediatric population, assuming that the risk of laryngospasm with both devices is equal.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Laryngospasm, Bradycardia
Keywords
Airway, Airway laryngeal mask, Endotracheal tube, Respiration artificial, Laryngospasm, Safety of airway laryngeal mask

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
338 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Airway laryngeal mask classic
Arm Type
Experimental
Arm Description
Ventilation with Airway laryngeal mask classic during surgery
Arm Title
endotracheal tube
Arm Type
Active Comparator
Arm Description
Ventilation with endotracheal tube during surgery
Intervention Type
Device
Intervention Name(s)
Airway laryngeal mask classic
Other Intervention Name(s)
airway laryngeal mask proseal
Intervention Description
This group includes patients with the randomization process are assigned to use Classic laryngeal mask as a method to secure the airway after induction of anesthesia, which will be maintained during surgery and removed the patient asleep once you are done the surgical procedure to determine the presence or absence of laryngospasm. The laryngeal mask mark to be used will laryngeal Mask Device ® which comes in different sizes and sterilized in ethylene oxide. The size of the Classic laryngeal mask is used according to the weight assigned
Intervention Type
Device
Intervention Name(s)
endotracheal tube
Other Intervention Name(s)
laryngeal tube
Intervention Description
This group includes patients with the randomization process are allocated to use endotracheal tube method for securing the airway after induction of anesthesia, which will be maintained during surgery and removed in the awake patient when you finish the surgical procedure to determine the presence or absence of laryngospasm. The marks of the endotracheal tube will be one of the following: Kendall Curity ®, Well Lead Medical ®, Meditec ®, which are not reusable. The size of the endotracheal tube be allocated according to age.
Primary Outcome Measure Information:
Title
Laryngospasm clinically manifested as inspiratory stridor and/or expiratory, no breath sounds, paradoxical movement of the thorax and abdomen and desaturation, bradycardia, central cyanosis.
Description
It should be noted that once the subject of study presents the primary outcome may end up changing the device to improve ventilation.
Time Frame
The appearance of the outcome will be measured from anesthetic induction until the patient is fully awake
Secondary Outcome Measure Information:
Title
Desaturation defined as SaO2 < 90% in pulse oximetry associated with laryngospasm
Time Frame
from anesthetic induction until the patient is fully awake
Title
Presence of bradycardia in the cardioscope as reported for the age.
Time Frame
from anesthetic induction until the patient is fully awake

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: ASA I and III children, 1-14 years of age Children scheduled for surgery or therapeutic procedures under general anesthesia and fasting as defined in the fasting guidelines Responsible adult patients whose accept and sign the informed consent of study Exclusion Criteria: Surgery of the head, neck, chest and/or abdomen (except the abdominal wall) Position different than the supine in surgery Malformations or anatomic abnormalities of the face and airway Procedures over 3 hours Patients with pulmonary aspiration risk: morbid obesity, intestinal obstruction, gastrointestinal bleeding, gastroparesis, gastroesophageal reflux Patients with limited mouth opening or cervical spine extension and classified as difficult airway
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olga Lucia Giraldo Salazar, MD, MsH
Organizational Affiliation
Foundation Hospital San Vicente de Paul, St. Vincent Foundation
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Foundation St. Vincent de Paul
City
Medellin
State/Province
Antioquia
ZIP/Postal Code
05001000
Country
Colombia

12. IPD Sharing Statement

Learn more about this trial

Noninferiority Clinical Trial With Laryngeal Mask and Endotracheal Tube

We'll reach out to this number within 24 hrs